Document Detail


Causes of death after therapy for early stage Hodgkin's disease entered on EORTC protocols. EORTC Lymphoma Cooperative Group.
MedLine Citation:
PMID:  2254106     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
The risk of dying from different causes after Hodgkin's disease (HD) therapy has been quantified from a series of 1,449 patients with early stages included in four successive clinical trials conducted by the European Organization for Research and Treatment of Cancer (EORTC) Lymphoma Cooperative Group since 1963. Overall, 240 patients died and the 15-year survival rate was 69% whereas the expected rate was 95%. The standardized mortality ratio (SMR) technique was used to quantify excess deaths as a function of time since first therapy. At each interval, SMR was significantly increased, giving: 0-3 year, 8.86 (p less than 0.001); 4-6 year, 9.25 (p less than 0.001); 7-9 year, 7.08 (p less than 0.001); 10-12 year, 9.53 (p less than 0.001); 13-15 year, 4.37 (p less than 0.01); and 16+ years, 3.80 (p less than 0.05). While the proportion of deaths as a consequence of HD progression, treatment side-effect, and intercurrent disease decreased with time, that of second cancer and cardiac failure peaked during the 10-12 year post-treatment interval. After 15 years of follow-up, the risk of dying from causes other than HD continued to increase. These findings indicate that although probably cured from HD, patients are at higher risk for death than expected, a risk that might be a consequence of therapy.
Authors:
M Henry-Amar; M Hayat; J H Meerwaldt; M Burgers; P Carde; R Somers; E M Noordijk; M Monconduit; J Thomas; J M Cosset
Related Documents :
16430946 - The significance of cytological mesothelial atypia diagnosed from peritoneal washings p...
10737166 - On-line haemodiafiltration versus low-flux haemodialysis. a prospective randomized study.
6651516 - Continuous ambulatory peritoneal dialysis catheters in children.
8611076 - Prognosis and treatment of peritonitis. do we need new scoring systems?
15156386 - Outcome after intra- and extra-corporeal laparoscopic appendectomy techniques.
11668406 - Endoscopic factors predisposing to rebleeding following endoscopic hemostasis in bleedi...
Publication Detail:
Type:  Clinical Trial; Journal Article; Multicenter Study    
Journal Detail:
Title:  International journal of radiation oncology, biology, physics     Volume:  19     ISSN:  0360-3016     ISO Abbreviation:  Int. J. Radiat. Oncol. Biol. Phys.     Publication Date:  1990 Nov 
Date Detail:
Created Date:  1991-01-18     Completed Date:  1991-01-18     Revised Date:  2004-11-17    
Medline Journal Info:
Nlm Unique ID:  7603616     Medline TA:  Int J Radiat Oncol Biol Phys     Country:  UNITED STATES    
Other Details:
Languages:  eng     Pagination:  1155-7     Citation Subset:  IM    
Affiliation:
Institut Gustave Roussy, Département de Statistique Médicale, Villejuif, France.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Adult
Cause of Death
Combined Modality Therapy
Female
France / epidemiology
Hodgkin Disease / epidemiology,  mortality,  therapy*
Humans
Male
Prospective Studies
Survival Analysis
Survival Rate

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Fractionated total body irradiation and bone marrow transplantation in acute lymphoblastic leukemia.
Next Document:  Combined therapy of localized Ewing's sarcoma of bone: analysis of results in 100 patients.